Greenleaf Trust Portfolio holdings
Greenleaf Trust is a privately held, trust-only bank that manages wealth and administers trusts for families. Bill Johnston started it in 1998 after national banks had swallowed up many regional and community banks, wanting a locally owned firm with fiduciary expertise that would serve families across generations. Johnston had already launched a sister firm, Greenleaf Asset Management, in 1991, and the two merged in 2002. The bank builds portfolios around what matters most to each client, whether personal, family-focused or charitable, and avoids selling its own proprietary products. It opened a separate bank, Greenleaf Trust Delaware, in 2018.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$16.2M |
| 2 |
Bankunited
BKU
|
+$12.7M |
| 3 |
Cinemark Holdings
CNK
|
+$6.51M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$1.97M |
| 5 |
NetApp
NTAP
|
+$1.55M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$34M |
| 2 |
SHPG
Shire pic
SHPG
|
+$21.1M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$18.3M |
| 4 |
NextEra Energy
NEE
|
+$9.46M |
| 5 |
Apple
AAPL
|
+$7.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 80.71% |
| 2 | Miscellaneous | 4.3% |
| 3 | Technology | 3.8% |
| 4 | Financials | 3.32% |
| 5 | Communication Services | 1.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Stryker
SYK
$124B
| $2.48B | 78.77% |
29,432,995
-415,966
| -1% | -$34M |
2013 Q2
4 quarters
|
|
2
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.97B
| $36.5M | 1.16% |
704,797
-13,657
| -2% | -$692K |
2013 Q2
4 quarters
|
|
3
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.56B
| $25.1M | 0.8% |
523,009
-11,397
| -2% | -$541K |
2013 Q2
4 quarters
|
|
4
Wells Fargo
WFC
$252B
| $24.2M | 0.77% |
461,123
+562
| +0.1% | +$28.3K |
2013 Q2
4 quarters
|
|
|
CELG
5
DELISTED
Celgene Corp
CELG
| $23.3M | 0.74% |
271,614
+6,888
| +3% | +$524K |
2013 Q2
4 quarters
|
|
6
Check Point Software Technologies
CHKP
$14.7B
| $21.5M | 0.68% |
320,355
-8,687
| -3% | -$571K |
2013 Q2
4 quarters
|
|
7
Markel Group
MKL
$23.7B
| $21.1M | 0.67% |
32,200
-252
| -0.8% | -$159K |
2013 Q2
4 quarters
|
|
8
People Inc
PPLI
$3.16B
| $19.9M | 0.63% |
1,609,855
+46,006
| +3% | +$551K |
2013 Q4
2 quarters
|
|
9
eBay
EBAY
$53.5B
| $18.5M | 0.59% |
877,222
+49,873
| +6% | +$1.09M |
2014 Q1
1 quarter
|
|
10
Broadridge
BR
$21.5B
| $18.5M | 0.59% |
443,730
-880
| -0.2% | -$34.4K |
2013 Q2
4 quarters
|
|
11
Broadcom
AVGO
$1.4T
| $18.3M | 0.58% |
2,539,070
-239,880
| -9% | -$1.61M |
2013 Q2
4 quarters
|
|
12
Target
TGT
$72B
| $18.3M | 0.58% |
315,480
+12,323
| +4% | +$725K |
2013 Q2
4 quarters
|
|
|
13
Apple
AAPL
$4.98T
| $16.3M | 0.52% |
700,824
-341,644
| -33% | -$7.27M |
2013 Q2
4 quarters
|
|
14
Norfolk Southern
NSC
$71.9B
| $16.2M | 0.51% |
157,179
-813
| -0.5% | -$79.8K |
2013 Q2
4 quarters
|
|
|
ESRX
15
DELISTED
Express Scripts Holding Company
ESRX
| $15.9M | 0.51% |
+229,873
| New | +$16.2M |
2014 Q2
0 quarters
|
|
16
Omnicom Group
OMC
$23.7B
| $15.9M | 0.5% |
222,904
+11,463
| +5% | +$798K |
2013 Q2
4 quarters
|
|
17
Chubb
CB
$139B
| $15.8M | 0.5% |
152,490
+122
| +0.1% | +$12.5K |
2013 Q2
4 quarters
|
|
18
PepsiCo
PEP
$193B
| $15.7M | 0.5% |
175,840
-786
| -0.4% | -$67.9K |
2013 Q2
4 quarters
|
|
19
Suncor Energy
SU
$79.1B
| $15.7M | 0.5% |
367,337
-6,479
| -2% | -$252K |
2013 Q2
4 quarters
|
|
|
20
NetApp
NTAP
$33.2B
| $14.7M | 0.47% |
402,809
+43,373
| +12% | +$1.55M |
2013 Q2
4 quarters
|
|
21
Albemarle
ALB
$11.7B
| $14.5M | 0.46% |
202,839
-1,235
| -0.6% | -$84.7K |
2013 Q2
4 quarters
|
|
22
Dover
DOV
$27.1B
| $14M | 0.45% |
191,276
-1,956
| -1% | -$137K |
2013 Q2
4 quarters
|
|
23
DELISTED
Iconix Brand Group, Inc.
ICON
| $13.6M | 0.43% |
31,674
+245
| +0.8% | +$101K |
2014 Q1
1 quarter
|
|
24
Aflac
AFL
$61.5B
| $13.4M | 0.42% |
429,754
+15,020
| +4% | +$469K |
2013 Q4
2 quarters
|
|
25
Franklin Templeton
BEN
$17.1B
| $13.2M | 0.42% |
228,777
+7,721
| +3% | +$422K |
2013 Q3
3 quarters
|
|
Similar funds
Greenleaf Trust's Q2 2014 Portfolio in Review
As of Q2 2014, Greenleaf Trust held 170 positions worth $3.15B, up 1.3% from $3.11B the previous quarter. Its ten largest holdings account for 85% of the portfolio.
Greenleaf Trust's Q2 2014 filing shows 12 new, 40 increased, 76 reduced and 8 closed positions. Its largest new stake was Express Scripts Holding Company: 229,873 shares worth $15.9M. The largest sale was Stryker, an estimated $34M.
By sector, the portfolio is most concentrated in Healthcare at 81% of assets, up from 80% a quarter earlier, followed by Miscellaneous and Technology.
- Greenleaf Trust's largest Q2 2014 buy was Express Scripts Holding Company: 229,873 shares worth $15.9M.
- Greenleaf Trust added most to iShares Core S&P 500 ETF in Q2 2014, an estimated $1.97M increase.
- Greenleaf Trust's biggest Q2 2014 reduction was Stryker, cutting an estimated $34M.
- Greenleaf Trust fully exited Bristol-Myers Squibb in Q2 2014, selling an estimated $750K.
- Greenleaf Trust's ten largest holdings make up 85% of its $3.15B portfolio in Q2 2014.
- Greenleaf Trust opened 12 new positions and closed 8 in Q2 2014.
- Greenleaf Trust's portfolio value rose 1.3% quarter-over-quarter to $3.15B.
Based on Greenleaf Trust's 13F filing for Q2 2014, filed 12 Aug 2014.